229 related articles for article (PubMed ID: 23278570)
1. IVIG and PLEX in the treatment of myasthenia gravis.
Bril V; Barnett-Tapia C; Barth D; Katzberg HD
Ann N Y Acad Sci; 2012 Dec; 1275():1-6. PubMed ID: 23278570
[TBL] [Abstract][Full Text] [Related]
2. Comparison of IVIg and PLEX in patients with myasthenia gravis.
Barth D; Nabavi Nouri M; Ng E; Nwe P; Bril V
Neurology; 2011 Jun; 76(23):2017-23. PubMed ID: 21562253
[TBL] [Abstract][Full Text] [Related]
3. IVIG Versus PLEX in the Treatment of Worsening Myasthenia Gravis: What is the Evidence?: A Critically Appraised Topic.
Dhawan PS; Goodman BP; Harper CM; Bosch PE; Hoffman-Snyder CR; Wellik KE; Wingerchuk DM; Demaerschalk BM
Neurologist; 2015 May; 19(5):145-8. PubMed ID: 25970838
[TBL] [Abstract][Full Text] [Related]
4. Changes in quality of life scores with intravenous immunoglobulin or plasmapheresis in patients with myasthenia gravis.
Barnett C; Wilson G; Barth D; Katzberg HD; Bril V
J Neurol Neurosurg Psychiatry; 2013 Jan; 84(1):94-7. PubMed ID: 23154126
[TBL] [Abstract][Full Text] [Related]
5. Treatment of myasthenia gravis acute exacerbations with intravenous immunoglobulin.
Gajdos P; Chevret S
Ann N Y Acad Sci; 2008; 1132():271-5. PubMed ID: 18096850
[TBL] [Abstract][Full Text] [Related]
6. Intravenous immunoglobulin for myasthenia gravis.
Gajdos P; Chevret S; Toyka KV
Cochrane Database Syst Rev; 2012 Dec; 12(12):CD002277. PubMed ID: 23235588
[TBL] [Abstract][Full Text] [Related]
7. Safety of plasma exchange therapy in patients with myasthenia gravis.
Ebadi H; Barth D; Bril V
Muscle Nerve; 2013 Apr; 47(4):510-4. PubMed ID: 23322564
[TBL] [Abstract][Full Text] [Related]
8. A comparison between IVIG and plasma exchange as preparations before thymectomy in myasthenia gravis patients.
Alipour-Faz A; Shojaei M; Peyvandi H; Ramzi D; Oroei M; Ghadiri F; Peyvandi M
Acta Neurol Belg; 2017 Mar; 117(1):245-249. PubMed ID: 27530310
[TBL] [Abstract][Full Text] [Related]
9. Surrogate therapeutic outcome measures in patients with myasthenia gravis.
Zinman L; Baryshnik D; Bril V
Muscle Nerve; 2008 Feb; 37(2):172-6. PubMed ID: 17918748
[TBL] [Abstract][Full Text] [Related]
10. IV immunoglobulin in patients with myasthenia gravis: a randomized controlled trial.
Zinman L; Ng E; Bril V
Neurology; 2007 Mar; 68(11):837-41. PubMed ID: 17353471
[TBL] [Abstract][Full Text] [Related]
11. IVIG treatment for myasthenia gravis: effectiveness, limitations, and novel therapeutic strategies.
Zinman L; Bril V
Ann N Y Acad Sci; 2008; 1132():264-70. PubMed ID: 18567877
[TBL] [Abstract][Full Text] [Related]
12. The quantitative myasthenia gravis score: comparison with clinical, electrophysiological, and laboratory markers.
Barnett C; Katzberg H; Nabavi M; Bril V
J Clin Neuromuscul Dis; 2012 Jun; 13(4):201-5. PubMed ID: 22622164
[TBL] [Abstract][Full Text] [Related]
13. Intravenous immunoglobulin for myasthenia gravis.
Gajdos P; Chevret S; Toyka K
Cochrane Database Syst Rev; 2008 Jan; (1):CD002277. PubMed ID: 18254004
[TBL] [Abstract][Full Text] [Related]
14. Predictors of response to immunomodulation in patients with myasthenia gravis.
Katzberg HD; Barnett C; Bril V
Muscle Nerve; 2012 May; 45(5):648-52. PubMed ID: 22499090
[TBL] [Abstract][Full Text] [Related]
15. Baseline Decrement in Patients with Mild Myasthenia Gravis Predicts Immunomodulation Treatment.
Abraham A; Lovblom LE; Bril V
Can J Neurol Sci; 2019 Nov; 46(6):762-766. PubMed ID: 31322098
[TBL] [Abstract][Full Text] [Related]
16. Cost-minimization analysis comparing intravenous immunoglobulin with plasma exchange in the management of patients with myasthenia gravis.
Furlan JC; Barth D; Barnett C; Bril V
Muscle Nerve; 2016 Jun; 53(6):872-6. PubMed ID: 26521889
[TBL] [Abstract][Full Text] [Related]
17. Comparison of plasmapheresis and intravenous immunoglobulin as maintenance therapies for juvenile myasthenia gravis.
Liew WK; Powell CA; Sloan SR; Shamberger RC; Weldon CB; Darras BT; Kang PB
JAMA Neurol; 2014 May; 71(5):575-80. PubMed ID: 24590389
[TBL] [Abstract][Full Text] [Related]
18. Intravenous immune globulin in myasthenia gravis.
Gajdos P
Clin Exp Immunol; 1994 Jul; 97 Suppl 1(Suppl 1):49-51. PubMed ID: 8033435
[TBL] [Abstract][Full Text] [Related]
19. Immunoglobulin treatment versus plasma exchange in patients with chronic moderate to severe myasthenia gravis.
Rønager J; Ravnborg M; Hermansen I; Vorstrup S
Artif Organs; 2001 Dec; 25(12):967-73. PubMed ID: 11843764
[TBL] [Abstract][Full Text] [Related]
20. Intravenous immunoglobulin maintenance treatment in myasthenia gravis: a randomized, controlled trial sample size simulation.
Eienbröker C; Seitz F; Spengler A; Kurz H; Seipelt M; Sommer N; Oertel WH; Timmesfeld N; Tackenberg B
Muscle Nerve; 2014 Dec; 50(6):999-1004. PubMed ID: 24710856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
